Jasper Therapeutics (JSPR) Competitor Comparison
We are evaluating the key criteria listed to compare Jasper Therapeutics (JSPR) against its competitors in the Biotechnology industry.
Market Capitalization
196 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
156 / 337Free Cashflow
166 / 352Quick Ratio
96 / 357Earnings per Share
309 / 359Dividend yield
0 / 6Total Cash
210 / 358Performance 3 years
230 / 368Performance 5 years
223 / 368Performance 10 years
192 / 368Linearity 3 years
287 / 368Linearity 5 years
194 / 368Linearity 10 years
154 / 367Total Rank
170 / 368Dividend Rank
49 / 368Valuation Rank
78 / 368Piotroski Rank
4 / 368Muliplier Rank
130 / 368Market Capitalization - JSPR ranking 196 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.